Clinical Trial
-
Biologics
BioRestorative Therapies Announces Activation of Northwell Health in the Company’s Phase 2 Clinical Trial Targeting Chronic Lumbar Disc Disease
–Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— –15 Clinical Sites Identified, 12…
Read More » -
Neuro
Mainstay Medical Announces Completion of Enrollment of RESTORE Clinical Trial of ReActiv8® in the United States
Randomized controlled clinical trial expected to validate effectiveness of ReActiv8® Restorative NeurostimulationTM vs. optimal medical management DUBLIN, August 29, 2023–(BUSINESS WIRE)–Mainstay Medical…
Read More » -
Top Stories
“Unify Medical Announces Commencement of Clinical Trial”
July 25, 2023 – OrthoSpineNews – Unify Medical, Inc., a privately-held, smart, surgical visualization technology company, announced it has entered into…
Read More » -
Spine
Synergy Spine Solutions Announces First Patient Enrolled in the Synergy Disc® 2-Level IDE Trial
LOUISVILLE, Colo., June 29, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc…
Read More » -
Spine
Relievant Medsystems Announces Pooled Three-Year Outcomes from Intracept Procedure that Demonstrate Long-Term Pain Relief and Reduced Opioid Use in Chronic Vertebrogenic Low Back Pain Patients
MINNEAPOLIS, June 15, 2023 (GLOBE NEWSWIRE) — Relievant Medsystems, a company dedicated to transforming the diagnosis and treatment of vertebrogenic low…
Read More » -
Spine
Centinel Spine® Completes Enrollment in First-of-its-Kind 2-Level IDE Trial Evaluating prodisc® C Match-the-Disc™ Cervical TDR System
The trial is designed to evaluate the safety and effectiveness of the prodisc C Vivo and prodisc C SK system by comparing…
Read More » -
Biologics
BioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
—Clinical data expected to be reviewed by independent data safety monitoring board (DSMB) as to initial safety dosing profile of BRTX-100– MELVILLE,…
Read More » -
Spine
Synergy Spine Solutions Completes Enrollment of 1-Level IDE Trial
LOUISVILLE, Colo., June 5, 2023 /PRNewswire/ — Synergy Spine Solutions Ltd, an innovative orthopaedic medical device developer focused on artificial cervical disc…
Read More » -
Spine
Aclarion Announces Publication of 2YR Outcomes in Groundbreaking Clinical Trial
Success rate at 2 years for discogenic low back pain surgeries was 85% for patients whose treatment strategy was consistent…
Read More » -
Biologics
Bone Biologics Receives Human Research Ethics Committee Approval to Begin Pilot Clinical Trial with NB1 in Spinal Fusion Patients in Australia
Company plans to begin 30-patient trial later this year April 11, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a…
Read More » -
Spine
Dr. Todd Lanman Begins Breakthrough Low Back Total Joint Replacement Clinical Trial in Beverly Hills with 3Spine, Inc.
BEVERLY HILLS, Calif., March 21, 2023 /PRNewswire/ — Todd Lanman, MD and Lanman Spinal Neurosurgery announced completion of the first lumbar total joint replacement procedure…
Read More » -
Spine
3Spine, Inc. Opens Innovative Clinical Trial for Spine Procedure with Pinehurst Surgical Clinic in Pinehurst, North Carolina
PINEHURST, N.C., March 6, 2023 –PRNewswire — Pinehurst Surgical Clinic today announced successful completion of the first series of cases in the BalancedBack…
Read More » -
Spine
Dr. Anton Jorgensen begins lumbar total Joint replacement clinical trial in San Antonio, TX with 3Spine, Inc.
Anton Jorgensen, MD SAN ANTONIO, March 6, 2023 –PRNewswire — Anton Jorgensen, MD and Ortho San Antonio announced today the first cases in the…
Read More » -
Spine
Bone Biologics Advances Preparations for NB1 Pilot Clinical Trial with Engagement of Contract Research Organization
January 26, 2023 BURLINGTON, Mass.–(BUSINESS WIRE)–Bone Biologics Corporation (NASDAQ: BBLG), a developer of orthobiologic products for spine fusion markets, announces…
Read More » -
Spine
Spinal Stabilization Technologies Ltd. Announces Start of LOPAIN 2 Clinical Trial in South America for Lumbar Degenerative Disc Disease
KILKENNY, Ireland, Nov. 16, 2022 /OrthoSpineNews/ — Spinal Stabilization Technologies (SST) has announced the start of the LOPAIN2 clinical trial of the PerQdisc™…
Read More »